in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Fine Chemicals: Growth Slows for Drugs and APIs
3:21 PM MST | January 9, 2012 | Deepti Ramesh
Global spending on medicines will reach almost $1.1 trillion by 2015, reflecting a slowing compound annual growth rate (CAGR) of 3%-6% over the next five years, says consulting firm IMS Health (Danbury, CT). That compares with 6.2% annual growth over the past five years. Lower levels of spending growth for medicines in the U.S., the ongoing impact of patent expiries in developed markets, continuing strong demand in emerging markets, and policy-driven changes in several countries are among the key factors that will influence future growth, IMS Health says. The...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee